List view / Grid view
14 January 2025 | By Dr Raminderpal Singh (Hitchhikers AI and 20/15 Visioneers), Nina Truter
In part two of the step-by-step scientific workflow for drug discovery series, Dr Raminderpal Singh and Nina Truter describe the functions of the workflow previously outlined and include key considerations.
24 February 2025 | By Dr Raminderpal Singh (Hitchhikers AI and 20/15 Visioneers)
In this article, Dr Raminderpal Singh explores the transformative impact of the Deepseek R1 open-source large language model on drug discovery. Its potential offers exciting opportunities for both scientists and software developers, marking a significant advancement for the life sciences community.
6 December 2024 | By Dr Raminderpal Singh (Hitchhikers AI and 20/15 Visioneers), Nina Truter
Explore the step-by-step scientific workflow behind drug discovery, from formulating hypotheses to analysing data, ensuring accurate and reliable results.
28 August 2025 | By Dr Raminderpal Singh (Hitchhikers AI and 20/15 Visioneers)
AI is starting to transform drug discovery, but progress is still slow and big challenges remain. Thibault Géoui explores the gaps, hurdles and breakthroughs needed before it can truly change pharma R&D.
21 August 2025 | By Dr Raminderpal Singh (Hitchhikers AI and 20/15 Visioneers)
Thibault Géoui explains why AI could finally help pharma overcome its productivity crisis and why the payoff won’t come as quickly as the optimists claim.
21 July 2025 | By Dr Raminderpal Singh (Hitchhikers AI and 20/15 Visioneers)
Why do so many drug candidates fail before reaching patients – and can AI help stop the losses? In Part 2, Layla Hosseini-Gerami of Ignota Labs outlines the scope of the toxicity problem and explains why failures often come too late to fix.
26 May 2025 | By Dr Raminderpal Singh (Hitchhikers AI and 20/15 Visioneers)
As AI reshapes scientific work, two founders debate how best to build tools scientists can trust — should we embed expertise into the model or the team? From agent-powered labs to hypothesis-generating machines, the future of drug discovery is being reimagined right now.
14 May 2025 | By Dr Raminderpal Singh (Hitchhikers AI and 20/15 Visioneers)
AI is reshaping drug discovery – but not without resistance. In this two-part conversation, André França and Eli Pollock share honest insights about the real barriers to AI adoption in life sciences and how embedding domain expertise into AI workflows might be the key to unlocking its full potential.
15 July 2024 | By Dr Raminderpal Singh (Hitchhikers AI and 20/15 Visioneers)
Recently there has been a flurry of announcements from AI-led biotechs around the potential of Large Language Models (LLM) in early drug discovery. In the second of a three-part series, Dr Raminderpal Singh presents an example of usage of ChatGPT, which demonstrates how accessible LLMs have become for lab scientists.
ON-DEMAND | By Drug Target Review
Manual processes are slowing down your lab. AI and automation can change that, if you know how to use them. In this free webinar, Dr Raminderpal Singh breaks down the technologies, data strategies and tools transforming early drug discovery, so you can stop guessing and start innovating.
24 September 2024 | By Dr Raminderpal Singh (Hitchhikers AI and 20/15 Visioneers)
In this four-part series, Dr Raminderpal Singh discusses the challenges surrounding limited data quality and offers some pragmatic solutions. In this fourth article, he talks to John Conway, Chief Visioneer Officer at 20/15 Visioneers for an expert perspective.
14 August 2025 | By Dr Raminderal Singh (Hitchhikers AI and 20/15 Visioneers
An interview with Thibault Géoui reveals why this technology wave might finally break through pharma's productivity crisis – and why it will take longer than the optimists claim.
14 February 2025 | By Dr Raminderpal Singh (Hitchhikers AI and 20/15 Visioneers), Nina Truter
Drug discovery scientists develop and test complex hypotheses using data and expertise, and build workflows to support this. In this third and final article, Dr Raminderpal Singh and Nina Truter summarise the tools used in the scientific workflow – and include key considerations.
24 October 2024 | By Dr Raminderpal Singh (Hitchhikers AI and 20/15 Visioneers)
In this article, Dr Raminderpal Singh speaks to Janette Thomas of Five Alarm Bio for a biotech CEO’s perspective on the complexity of data faced by both large and small biotechs. Janette is on a mission to develop drugs targeting the chronic diseases associated with ageing. She shares her insights…
14 October 2024 | By Dr Raminderpal Singh (Hitchhikers AI and 20/15 Visioneers)
In this article, Dr Raminderpal Singh speaks to Neil Wilkie of Mironid Ltd. for a biotech CEO’s perspective on the transformative potential of AI, and the importance of bridging communication gaps between scientific and technical teams to drive innovation and efficiency in the pharmaceutical industry.
